Cross Country Healthcare (NASDAQ:CCRN – Get Free Report) will likely be issuing its Q2 2026 results before the market opens on Wednesday, August 5th. Analysts expect the company to announce earnings of $0.03 per share and revenue of $242.6740 million for the quarter. Interested persons may visit the the company’s upcoming Q2 2026 earning overview page for the latest details on the call scheduled for Wednesday, August 12, 2026 at 4:00 PM ET.
Cross Country Healthcare (NASDAQ:CCRN – Get Free Report) last issued its earnings results on Thursday, May 7th. The business services provider reported ($0.03) earnings per share for the quarter, topping the consensus estimate of ($0.05) by $0.02. Cross Country Healthcare had a negative net margin of 9.84% and a negative return on equity of 0.74%. The company had revenue of $241.06 million during the quarter, compared to the consensus estimate of $237.06 million. On average, analysts expect Cross Country Healthcare to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.
Cross Country Healthcare Stock Performance
Shares of CCRN stock opened at $13.25 on Monday. Cross Country Healthcare has a 52-week low of $7.43 and a 52-week high of $14.99. The firm has a market capitalization of $428.05 million, a PE ratio of -4.34, a PEG ratio of 14.32 and a beta of 0.45. The stock has a fifty day simple moving average of $13.19 and a two-hundred day simple moving average of $10.98.
Institutional Inflows and Outflows
Analysts Set New Price Targets
A number of research firms have recently weighed in on CCRN. Weiss Ratings raised Cross Country Healthcare from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Thursday, July 16th. Citigroup downgraded Cross Country Healthcare from a “market outperform” rating to a “market perform” rating in a research note on Thursday, May 7th. Citizens Jmp cut shares of Cross Country Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Thursday, May 7th. Truist Financial upped their target price on shares of Cross Country Healthcare from $10.00 to $13.25 and gave the stock a “hold” rating in a research report on Monday, May 11th. Finally, Wedbush cut shares of Cross Country Healthcare from an “outperform” rating to a “hold” rating and cut their target price for the company from $15.00 to $13.25 in a research note on Thursday, May 7th. Nine equities research analysts have rated the stock with a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, Cross Country Healthcare currently has an average rating of “Reduce” and a consensus price target of $12.05.
Read Our Latest Analysis on Cross Country Healthcare
Cross Country Healthcare Company Profile
Cross Country Healthcare, Inc, headquartered in Boca Raton, Florida, is a leading provider of healthcare workforce solutions in the United States. The company specializes in the recruitment, placement and management of nursing and allied health professionals on both a travel and permanent basis. Through its integrated platform, Cross Country Healthcare serves hospitals, health systems, and long-term care facilities by matching qualified clinical talent with patient care needs across diverse care settings.
The company’s core service offerings include travel nurse and allied health staffing, per diem staffing, permanent placement services, and managed services programs.
Recommended Stories
- Five stocks we like better than Cross Country Healthcare
- 3 Low-Volatility Plays Quietly Making a Name For Themselves
- ASML’s Dividend Growth Adds a Quiet Income Angle to Its AI Chip Story
- 2 Consumer Staples Stocks Giving Investors a Break From the AI Trade
- 3 Fixed-Income ETFs Show Why Yield Is Only Part of the Income Story
Receive News & Ratings for Cross Country Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cross Country Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
